274 studies found for:    United States, Texas | United States, Texas | cook children's
Show Display Options
Rank Status Study
21 Active, not recruiting Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Conditions: Adult Rhabdomyosarcoma;   Alveolar Childhood Rhabdomyosarcoma;   Embryonal Childhood Rhabdomyosarcoma;   Metastatic Childhood Soft Tissue Sarcoma;   Previously Untreated Childhood Rhabdomyosarcoma;   Stage IV Adult Soft Tissue Sarcoma
Interventions: Biological: cixutumumab;   Drug: doxorubicin hydrochloride;   Drug: irinotecan hydrochloride;   Drug: liposomal vincristine sulfate;   Drug: ifosfamide;   Drug: etoposide;   Drug: cyclophosphamide;   Biological: dactinomycin;   Drug: temozolomide;   Other: laboratory biomarker analysis
22 Recruiting International Pediatric Adrenocortical Tumor Registry
Condition: Adrenocortical Tumor
Intervention:
23 Withdrawn Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Peramivir in Children With Influenza
Condition: Influenza
Intervention: Drug: Peramivir
24 Recruiting Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)
Condition: Chronic GVHD
Interventions: Drug: Sirolimus + calcineurin inhibitor + prednisone;   Drug: Sirolimus + prednisone
25 Recruiting Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
Conditions: Disseminated Neuroblastoma;   Ganglioneuroblastoma;   Localized Resectable Neuroblastoma;   Localized Unresectable Neuroblastoma;   Regional Neuroblastoma;   Stage 4S Neuroblastoma
Interventions: Other: laboratory biomarker analysis;   Other: cytology specimen collection procedure
26 Active, not recruiting Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Untreated Adult Acute Lymphoblastic Leukemia;   Untreated Childhood Acute Lymphoblastic Leukemia
Intervention: Other: laboratory biomarker analysis
27 Active, not recruiting
Has Results
ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment
Conditions: Disseminated Neuroblastoma;   Recurrent Neuroblastoma
Interventions: Drug: ABT-751;   Procedure: quality-of-life assessment
28 Active, not recruiting Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study
Conditions: Childhood Absence Epilepsy;   Petit Mal Epilepsy;   Epilepsy;   Seizures
Interventions: Drug: ethosuximide;   Drug: lamotrigine;   Drug: valproic acid
29 Active, not recruiting Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
Conditions: Childhood Embryonal Tumor;   Childhood Extracranial Germ Cell Tumor;   Childhood Extragonadal Germ Cell Tumor;   Childhood Malignant Ovarian Germ Cell Tumor;   Childhood Malignant Testicular Germ Cell Tumor;   Childhood Teratoma;   Ovarian Embryonal Carcinoma;   Ovarian Yolk Sac Tumor;   Stage II Malignant Testicular Germ Cell Tumor;   Stage IIA Ovarian Germ Cell Tumor;   Stage IIB Ovarian Germ Cell Tumor;   Stage IIC Ovarian Germ Cell Tumor;   Stage III Malignant Testicular Germ Cell Tumor;   Stage IIIA Ovarian Germ Cell Tumor;   Stage IIIB Ovarian Germ Cell Tumor;   Stage IIIC Ovarian Germ Cell Tumor;   Testicular Choriocarcinoma and Yolk Sac Tumor;   Testicular Embryonal Carcinoma
Interventions: Procedure: conventional surgery;   Drug: cisplatin;   Drug: etoposide;   Biological: bleomycin sulfate;   Other: laboratory biomarker analysis
30 Recruiting Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Conditions: Recurrent Adult Hodgkin Lymphoma;   Recurrent Adult T-cell Leukemia/Lymphoma;   Recurrent/Refractory Childhood Hodgkin Lymphoma;   Stage I Adult Hodgkin Lymphoma;   Stage I Adult T-cell Leukemia/Lymphoma;   Stage I Childhood Hodgkin Lymphoma;   Stage II Adult Hodgkin Lymphoma;   Stage II Adult T-cell Leukemia/Lymphoma;   Stage II Childhood Hodgkin Lymphoma;   Stage III Adult Hodgkin Lymphoma;   Stage III Adult T-cell Leukemia/Lymphoma;   Stage III Childhood Hodgkin Lymphoma;   Stage IV Adult Hodgkin Lymphoma;   Stage IV Adult T-cell Leukemia/Lymphoma;   Stage IV Childhood Hodgkin Lymphoma
Interventions: Other: Anthropometry;   Other: Serum Biomarkers;   Other: Diagnostic/symptom checklist;   Procedure: Echocardiogram;   Other: 6 minute walk test (6MWT);   Behavioral: Participant Questionnaires (ages >14 years only)
31 Active, not recruiting Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Conditions: Stage I Wilms Tumor;   Stage II Wilms Tumor;   Stage III Wilms Tumor
Interventions: Procedure: therapeutic conventional surgery;   Drug: vincristine sulfate;   Biological: dactinomycin;   Drug: doxorubicin hydrochloride;   Radiation: 3-dimensional conformal radiation therapy
32 Completed Valganciclovir in Congenital CMV Infants
Condition: Cytomegalovirus Infections
Interventions: Drug: Valganciclovir;   Drug: Ganciclovir
33 Recruiting Study of Kidney Tumors in Young Patients
Conditions: Clear Cell Sarcoma of the Kidney;   Congenital Mesoblastic Nephroma;   Diffuse Hyperplastic Perilobar Nephroblastomatosis;   Rhabdoid Tumor of the Kidney;   Stage I Renal Cell Cancer;   Stage I Wilms Tumor;   Stage II Renal Cell Cancer;   Stage II Wilms Tumor;   Stage III Renal Cell Cancer;   Stage III Wilms Tumor;   Stage IV Renal Cell Cancer;   Stage IV Wilms Tumor;   Stage V Wilms Tumor
Interventions: Other: laboratory biomarker analysis;   Other: cytology specimen collection procedure
34 Terminated Feeding Intervention for Infants With Crying
Condition: Crying
Interventions: Other: Milk based infant formula with probiotic;   Other: Milk based infant formula
35 Recruiting Trial of Patterned Oral Somatosensory Entrainment for Shortening Time to Oral Feeding
Condition: Premature Birth
Intervention: Device: NTrainer® Intervention
36 Active, not recruiting Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
Conditions: Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma;   Stage III Childhood Hodgkin Lymphoma;   Stage IV Childhood Hodgkin Lymphoma
Interventions: Biological: bleomycin sulfate;   Drug: doxorubicin hydrochloride;   Drug: liposomal vincristine sulfate;   Drug: vinorelbine tartrate;   Drug: cyclophosphamide;   Drug: etoposide phosphate;   Drug: prednisone;   Biological: filgrastim;   Drug: ifosfamide
37 Active, not recruiting Evaluating the Safety and Effectiveness of Bone Marrow Transplants in Children With Sickle Cell Disease (BMT CTN #0601) (The SCURT Study)
Condition: Sickle Cell Disease
Intervention: Biological: Hematopoietic Stem Cell Transplantation
38 Active, not recruiting Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma
Conditions: Childhood Alveolar Soft-part Sarcoma;   Childhood Angiosarcoma;   Childhood Epithelioid Sarcoma;   Childhood Fibrosarcoma;   Childhood Gliosarcoma;   Childhood Leiomyosarcoma;   Childhood Liposarcoma;   Childhood Neurofibrosarcoma;   Childhood Synovial Sarcoma;   Previously Treated Childhood Rhabdomyosarcoma;   Recurrent Childhood Rhabdomyosarcoma;   Recurrent Childhood Soft Tissue Sarcoma;   Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Recurrent Osteosarcoma
Interventions: Biological: cixutumumab;   Drug: temsirolimus;   Other: laboratory biomarker analysis
39 Completed Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
Condition: Gram Positive Bacterial Infection
Intervention: Drug: Daptomycin
40 Active, not recruiting Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma
Conditions: Childhood Cerebral Astrocytoma/Malignant Glioma;   Childhood High-grade Cerebellar Astrocytoma;   Childhood High-grade Cerebral Astrocytoma;   Childhood Infratentorial Ependymoma;   Childhood Mixed Glioma;   Childhood Oligodendroglioma;   Childhood Supratentorial Ependymoma;   Recurrent Childhood Cerebellar Astrocytoma;   Recurrent Childhood Cerebral Astrocytoma;   Recurrent Childhood Ependymoma;   Recurrent Childhood Subependymal Giant Cell Astrocytoma
Interventions: Drug: sunitinib malate;   Other: diagnostic laboratory biomarker analysis;   Other: pharmacological study

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years